INM - InMed Pharmaceuticals Inc.
3.13
0.030 0.958%
Share volume: 43,000
Last Updated: Tue 04 Feb 2025 10:00:00 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.24%
PREVIOUS CLOSE
CHG
CHG%
$3.10
0.06
0.02%
Summary score
29%
Profitability
0%
Dept financing
14%
Liquidity
75%
Performance
50%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Long-term ratios 2021 - 2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-15.86%
Return on sales
-149.49%
Return on invested capital
0%
Total debt ratio
19.59%
Debt ratio change over timeo
0%
Current Ratio
5.35%
Quick Ratio
4.6%
Cash Position Ratio
4.06%
Short-term ratios 2024 - 2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-15.86%
Return on sales
-149.49%
Return on invested capital
0%
Total debt ratio
19.59%
Debt ratio change over timeo
0%
Current Ratio
5.35%
Quick Ratio
4.6%
Cash Position Ratio
4.06%
Last quarter ratios 2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-16.58%
Return on sales
-138.72%
Return on invested capital
0%
Total debt ratio
19.78%
Debt ratio change over time
0%
Current Ratio
5.07%
Quick Ratio
4.22%
Cash Position Ratio
3.89%
Performance ratios (change over 4 years) 2021 - 2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | INM | LLY | NVO | JNJ |
|---|---|---|---|---|
| Return on equity | 0% | 15.38% | 0% | 8.06% |
| Return on assets | -15.86% | 4.16% | 0% | 3.11% |
| Return on sales | -149.49% | 28.02% | 0% | 25.91% |
| Return on invested capital | 0% | 9.98% | 0% | 8.2% |
| Profitability | 0% | 100% | 0% | 75% |
| Total debt ratio | 19.59% | 81.07% | 0% | 59.57% |
| Debt ratio change over time | 0% | -6.72% | 0% | -34.01% |
| Dept financing | 31% | 25% | 0% | 18% |
| Current Ratio | 5.35% | 1.19% | 0% | 1.06% |
| Quick Ratio | 4.6% | 0.92% | 0% | 0.83% |
| Cash Position Ratio | 4.06% | 0.13% | 0% | 0.44% |
| Liquididy | 75% | 12% | 0% | 14% |
| Short-term ratios | INM | LLY | NVO | JNJ |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 6.55% |
| Return on assets | -15.86% | 3.5% | 0% | 2.83% |
| Return on sales | -149.49% | 23.1% | 0% | 26.38% |
| Return on invested capital | 0% | 0% | 0% | 6.76% |
| Profitability | 0% | 47% | 0% | 95% |
| Total debt ratio | 19.59% | 81.15% | 0% | 60.55% |
| Debt ratio change over time | 0% | 6.29% | 0% | 9.08% |
| Dept financing | 6% | 42% | 0% | 44% |
| Current Ratio | 5.35% | 1.19% | 0% | 1.06% |
| Quick Ratio | 4.6% | 0.92% | 0% | 0.83% |
| Cash Position Ratio | 4.06% | 0.13% | 0% | 0.44% |
| Liquididy | 75% | 11% | 0% | 12% |